Mitsubishi UFJ Trust & Banking’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Sell
82,441
-3,041
-4% -$331K 0.03% 462
2026
Q1
$7.9M Sell
85,482
-60,403
-41% -$6.06M 0.02% 553
2025
Q4
$14.9M Sell
145,885
-32,424
-18% -$2.9M 0.04% 406
2025
Q3
$11.1M Sell
178,309
-5,134
-3% -$279K 0.02% 536
2025
Q2
$9.55M Sell
183,443
-86,896
-32% -$3.88M 0.02% 554
2025
Q1
$11.5M Sell
270,339
-22,633
-8% -$976K 0.03% 508
2024
Q4
$8.95M Sell
292,972
-37,100
-11% -$1.04M 0.02% 592
2024
Q3
$7.57M Sell
330,072
-9,018
-3% -$255K 0.02% 641
2024
Q2
$9.79M Sell
339,090
-63,220
-16% -$1.47M 0.02% 558
2024
Q1
$8.3M Buy
+402,310
New +$8.62M 0.02% 597

Other funds holding GH

Mitsubishi UFJ Trust & Banking's GH Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking reduced its Guardant Health (GH) stake by 3.6% in Q2 2026, selling an estimated $331K and leaving 82,441 shares worth $12.4M. The position accounts for 0.03% of the portfolio, ranked #462.

Mitsubishi UFJ Trust & Banking first reported a position in GH in Q1 2024 and has held it in 10 quarters since. The position peaked at $14.9M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 82,441 shares of Guardant Health worth $12.4M as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking sold 3,041 Guardant Health shares in Q2 2026, an estimated $331K.
  • Guardant Health made up 0.03% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #462 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Guardant Health in Q1 2024 and has held it in 10 quarters since.
  • Mitsubishi UFJ Trust & Banking's Guardant Health position peaked at $14.9M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.